1725 related articles for article (PubMed ID: 17384434)
1. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.
Crouse JR; Raichlen JS; Riley WA; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Bots ML;
JAMA; 2007 Mar; 297(12):1344-53. PubMed ID: 17384434
[TBL] [Abstract][Full Text] [Related]
2. Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study.
Crouse JR; Bots ML; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Raichlen JS;
Eur J Cardiovasc Prev Rehabil; 2010 Apr; 17(2):223-9. PubMed ID: 20038840
[TBL] [Abstract][Full Text] [Related]
3. Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study.
Bots ML; Palmer MK; Dogan S; Plantinga Y; Raichlen JS; Evans GW; O'Leary DH; Grobbee DE; Crouse JR;
J Intern Med; 2009 Jun; 265(6):698-707. PubMed ID: 19298496
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein lowering with rosuvastatin in the METEOR study.
Peters SA; Palmer MK; Grobbee DE; Crouse JR; O'Leary DH; Raichlen JS; Bots ML
J Intern Med; 2010 Aug; 268(2):155-61. PubMed ID: 20412373
[TBL] [Abstract][Full Text] [Related]
5. Rosuvastatin Slows Progression of Carotid Intima-Media Thickness: The METEOR-China Randomized Controlled Study.
Zheng H; Li H; Wang Y; Li Z; Hu B; Li X; Fu L; Hu H; Nie Z; Zhao B; Wei D; Karlson BW; Bots ML; Meng X; Chen Y; Wang Y;
Stroke; 2022 Oct; 53(10):3004-3013. PubMed ID: 36017704
[TBL] [Abstract][Full Text] [Related]
6. Manual or semi-automated edge detection of the maximal far wall common carotid intima-media thickness: a direct comparison.
Peters SA; den Ruijter HM; Palmer MK; Grobbee DE; Crouse JR; O'Leary DH; Evans GW; Raichlen JS; Lind L; Bots ML;
J Intern Med; 2012 Mar; 271(3):247-56. PubMed ID: 21726301
[TBL] [Abstract][Full Text] [Related]
7. METEOR Trial Reports on the Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals with Subclinical Atherosclerosis.
Haddad RM; Ballantyne CM
Phys Sportsmed; 2010 Jun; 38(2):180-2. PubMed ID: 20631478
[TBL] [Abstract][Full Text] [Related]
8. Extensive or restricted ultrasound protocols to measure carotid intima-media thickness: analysis of completeness rates and impact on observed rates of change over time.
Peters SA; den Ruijter HM; Palmer MK; Grobbee DE; Crouse JR; O'Leary DH; Evans GW; Raichlen JS; Bots ML;
J Am Soc Echocardiogr; 2012 Jan; 25(1):91-100. PubMed ID: 21982737
[TBL] [Abstract][Full Text] [Related]
9. Carotid intima-media thickness in low-risk individuals with asymptomatic atherosclerosis: baseline data from the METEOR study.
Crouse JR; Grobbee DE; O'Leary DH; Bots ML; Evans GW; Palmer MK; Riley WA; Raichlen JS;
Curr Med Res Opin; 2007 Mar; 23(3):641-8. PubMed ID: 17355745
[TBL] [Abstract][Full Text] [Related]
10. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
Nissen SE; Nicholls SJ; Sipahi I; Libby P; Raichlen JS; Ballantyne CM; Davignon J; Erbel R; Fruchart JC; Tardif JC; Schoenhagen P; Crowe T; Cain V; Wolski K; Goormastic M; Tuzcu EM;
JAMA; 2006 Apr; 295(13):1556-65. PubMed ID: 16533939
[TBL] [Abstract][Full Text] [Related]
11. Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin in subclinical atherosclerosis--the rationale and methodology of the METEOR study.
Crouse JR; Grobbee DE; O'Leary DH; Bots ML; Evans GW; Palmer MK; Riley WA; Raichlen JS;
Cardiovasc Drugs Ther; 2004 May; 18(3):231-8. PubMed ID: 15229392
[TBL] [Abstract][Full Text] [Related]
12. Biologically implausible carotid intima-media thickness measurement values: effects on rate of change over time.
Peters SA; den Ruijter HM; Palmer MK; Grobbee DE; Crouse JR; O'Leary DH; Evans GW; Raichlen JS; Bots ML;
Curr Med Res Opin; 2012 Jun; 28(6):891-9. PubMed ID: 22536884
[TBL] [Abstract][Full Text] [Related]
13. Algorithms to measure carotid intima-media thickness in trials: a comparison of reproducibility, rate of progression and treatment effect.
Dogan S; Plantinga Y; Crouse JR; Evans GW; Raichlen JS; O'Leary DH; Palmer MK; Grobbee DE; Bots ML;
J Hypertens; 2011 Nov; 29(11):2181-93. PubMed ID: 21918474
[TBL] [Abstract][Full Text] [Related]
14. The use of plaque score measurements to assess changes in atherosclerotic plaque burden induced by lipid-lowering therapy over time: the METEOR study.
Peters SA; Dogan S; Meijer R; Palmer MK; Grobbee DE; Crouse JR; O'Leary DH; Evans GW; Raichlen JS; Bots ML
J Atheroscler Thromb; 2011; 18(9):784-95. PubMed ID: 21617330
[TBL] [Abstract][Full Text] [Related]
15. Prevention of atherosclerosis in patients living with HIV.
De Lorenzo F; Boffito M; Collot-Teixeira S; Gazzard B; McGregor JL; Shotliff K; Xiao H
Vasc Health Risk Manag; 2009; 5(1):287-300. PubMed ID: 19436663
[TBL] [Abstract][Full Text] [Related]
16. Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial.
Tam LS; Li EK; Shang Q; Tomlinson B; Lee VW; Lee KK; Li M; Kuan WP; Li TK; Tseung L; Yip GW; Freedman B; Yu CM
Scand J Rheumatol; 2011 Nov; 40(6):411-21. PubMed ID: 21867445
[TBL] [Abstract][Full Text] [Related]
17. Rosuvastatin reduces intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease: the Asymptomatic Carotid Atherosclerotic Disease in Manfredonia (ACADIM) Study.
Riccioni G; Bazzano LA; Bucciarelli T; Mancini B; di Ilio E; D'Orazio N
Expert Opin Pharmacother; 2008 Oct; 9(14):2403-8. PubMed ID: 18778179
[TBL] [Abstract][Full Text] [Related]
18. Effects of statins on progression of carotid atherosclerosis as measured by carotid intimal--medial thickness: a meta-analysis of randomized controlled trials.
Bedi US; Singh M; Singh PP; Bhuriya R; Bahekar A; Molnar J; Khosla S; Arora R
J Cardiovasc Pharmacol Ther; 2010 Sep; 15(3):268-73. PubMed ID: 20472815
[TBL] [Abstract][Full Text] [Related]
19. Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial.
Lind L; Peters SA; den Ruijter HM; Palmer MK; Grobbee DE; Crouse JR; O'Leary DH; Evans GW; Raichlen JS; Bots ML;
J Am Soc Echocardiogr; 2012 Oct; 25(10):1120-1127.e1. PubMed ID: 22884641
[TBL] [Abstract][Full Text] [Related]
20. Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease.
Riccioni G; Cipollone F; Santovito D; Scotti L; D'Orazio N; Mezzetti A; Bucciarelli T
Expert Opin Pharmacother; 2011 Dec; 12(17):2599-604. PubMed ID: 21999752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
